Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients With Systemic Sclerosis
- Resource Type
- Authors
- Suzana Jordan; Jeroen J. Bax; M. Boonstra; Victoria Delgado; Bas Bloem; D Cassani; Suzanne E. van Wijngaarden; Jeska K de Vries-Bouwstra; Oliver Distler; Nina Ajmone Marsan; Felix C. Tanner
- Source
- STARTPAGE=2273;ENDPAGE=2276;TITLE=None
- Subject
- medicine.medical_specialty
Time Factors
medicine.drug_class
610 Medicine & health
030204 cardiovascular system & hematology
Ventricular Function, Left
2705 Cardiology and Cardiovascular Medicine
Scleroderma
030218 nuclear medicine & medical imaging
03 medical and health sciences
0302 clinical medicine
Predictive Value of Tests
Risk Factors
Cause of Death
Internal medicine
Natriuretic Peptide, Brain
medicine
Natriuretic peptide
Humans
2741 Radiology, Nuclear Medicine and Imaging
Radiology, Nuclear Medicine and imaging
In patient
Progression-free survival
Stage (cooking)
Netherlands
Cause of death
Scleroderma, Systemic
business.industry
10051 Rheumatology Clinic and Institute of Physical Medicine
Stroke Volume
Stroke volume
medicine.disease
Peptide Fragments
Progression-Free Survival
Cardiovascular Diseases
Echocardiography
Predictive value of tests
Disease Progression
10209 Clinic for Cardiology
Cardiology
Cardiology and Cardiovascular Medicine
business
Biomarkers
- Language
- ISSN
- 1936-878X
Systemic sclerosis (SSc) is associated with increased mortality mostly due to cardiovascular or pulmonary causes [(1,2)][1]. Diagnosis of cardiac involvement remains challenging, especially at an early stage because standard echocardiography lacks sensitivity to detect subtle myocardial dysfunction